InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Schneider Jerry A., Director. Director active across 1 companies, notably Kiromic Biopharma, Inc.. Cumulatively, 2 disclosures have been logged. Total volume traded: €60k. The latest transaction was filed on 24 May 2021 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
€29,9235,000 shares@ €5.9846100.0% of flow
Common Stock
SEC:0001104659-21-072372·
Ideal exit: 18 Feb 2022 (T+270)
€29,9235,000 shares@ €5.984650.0% of flow
Common Stock
SEC:0001104659-21-072372:0·
Ideal exit: 18 Feb 2022 (T+270)
2 of 2 declarations
About Schneider Jerry A.
Jerry A. Schneider is a Director at Kiromic Biopharma, Inc. As a board member, he provides his expertise to guide the company's strategy and ensure good governance. His experience is valuable for Kiromic.
